Rational Tuning of CAR Tonic Signaling Yields Superior T-Cell Therapy for Cancer
X. Chen, M. Khericha, A. Lakhani, X. Meng, E. Salvestrini, L. C. Chen, A. Shafer, A. Alag, Y. Ding, D. Nicolaou, J. O. Park, Y. Y. Chen
This study shows that tuning CAR tonic signaling improves T-cell therapy efficacy by designing CARs with low but non-zero tonic signaling, enhancing anti-tumor activity in mouse models.
bioRxiv · Oct 1, 2020 · PreprintBioengineering